Related Experiment Videos
[Current evidence-based medicine for early intervention in diabetes]
1Division of Diabetes,Metabolism and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 23, 2008
Summary
Early intervention in diabetes management, including lifestyle changes and medications, improves glycemic control. Starting insulin therapy sooner is also recommended for better outcomes in diabetes care.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Pharmacology
Background:
- Diabetes management has evolved with a focus on early intervention strategies.
- Current approaches include lifestyle modifications, pharmacological agents, and patient education.
Purpose of the Study:
- To review current evidence on early intervention strategies in diabetes management.
- To highlight the role of various treatments in improving glycemic control.
Main Methods:
- Review of clinical studies and recent data on diabetes interventions.
- Analysis of pharmacological agents and lifestyle adjustments for early treatment.
Main Results:
- Early pharmacological treatments like sulfonylureas, metformin, alpha-glucosidase inhibitors, pioglitazone, and glinides are effective for persistent hyperglycemia.
- Insulin therapy initiated early in the disease progression shows promising results.
- Combined lifestyle adjustments and pharmacological agents lead to significant glycemic control improvements.
Conclusions:
- Early intervention, encompassing lifestyle changes and timely pharmacological treatment, is crucial for effective diabetes management.
- Further research is needed to determine optimal intervention timing to prevent disease progression and complications.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...